Oruka Therapeutics, Inc. (ORKA)
(Delayed Data from NSDQ)
$16.58 USD
+0.37 (2.28%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $16.56 -0.02 (-0.12%) 6:14 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ORKA 16.58 +0.37(2.28%)
Will ORKA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ORKA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ORKA
Is ORKA set to rally? Crossed Above 20 Day Moving Average shows up after rocketing 8.79%
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
ORKA Stock Rating Update: Clear Street Maintains 'Buy' Rating | ORKA Stock News
Lyft, Oruka Therapeutics, Roivant Sciences, Workday And Other Big Stocks Moving Higher On Wednesday
Biggest stock movers Wednesday: NFE, WDAY, LYFT, and more